Current contraceptive research and development

Adolescent Medicine Clinics

Volumn 16, Issue 3 SPEC. ISS., 2005, Pages 617-633

  Reape, Kathleen Z ^a  

^a Data Management and Biostatistics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 25844525528     PISSN: 15473368     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.admecli.2005.05.009     Document Type: Review

References (28)

1. L. Speroff, R. Glass, and N. Kase Clinical gynecologic endocrinology and infertility 6th edition 1999 Lippincott Williams & Wilkins Baltimore (MD)
2. F. Anderson, and H. Hait A multi-center, randomized study of an extended cycle oral contraceptive Contraception 68 2 2003 89 96
3. L. Speroff, and P. Darney A clinical guide for contraception 2nd edition 1996 Williams & Wilkins Baltimore (MD)
4. P. Sulak, R. Scow, and C. Preece Hormone withdrawal symptoms in oral contraceptive users Obstet Gynecol 95 2 2000 261 266
5. P. Sulak, B. Cressman, and E. Waldrop Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms Obstet Gynecol 89 2 1997 179 183
6. W. Schlaff, A. Lynch, and H. Hughes Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression Am J Obstet Gynecol 190 4 2004 943 951
7. Investor relations Available at: http://www.barrlabs.com/home.html Accessed November 10, 2004
8. M. Dey, and G. Constantine Wyeth: the leader in women's health-yesterday, today, and tomorrow. Sexuality Reproduction & Menopause 2 3 2004 181 184
9. Investor Relations. Wyeth analyst meeting, June 2, 2004. Emerging commercial candidates Available at: http://www.wyeth.com/index.asp Accessed November 10, 2004
10. Research and Development Available at: http://www.schering.de Accessed November 10, 2004
11. J. Aarts, and L. Miller Design of an open-label, randomized trial of continuous regimens with NuvaRing Obstet Gynecol 101 4 2003 14S
12. US prescribing information. Seasonale. Revised September 2003
13. R. Sitruk-Ware Progestogens in hormonal replacement therapy: new molecules, risks, and benefits Menopause 9 1 2002 6 15
14. Biomedicine. Product development Available at: http://www.popcouncil.org Accessed November 11, 2004
15. I.M. Spitz, H. Croxatto, and A. Robbins Antiprogestins: mechanisms of action and contraceptive potential Annu Rev Pharmacol Toxicol 36 1996 47 81
16. From pipeline to market. R&D Directions 10 6 2004 35 74
17. Drug development Available at: http://www.organon.com Accessed November 11, 2004
18. G. Csemiczky, T. Dieben, and H. Bennink The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17-β estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg desogestrel only for 7 days Contraception 54 1996 333 338
19. Press releases Available at: http://agiletherapeutics.com Accessed November 11, 2004
20. T. Dieben, F. Roumen, and D. Apter Efficacy, cycle control and user acceptability of a novel combined contraceptive vaginal ring Obstet Gynecol 100 2002 585 593
21. A. Novak, C. de la Loge, and L. Abetz The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability Contraception 67 3 2003 187 194
22. P. Darney, J. Jain, and A. Jakimiuk Zero pregnancies with new low-dose depot medroxyprogesterone acetate subcutaneous injection for contraception Fertil Steril 82 Suppl 2 2004 S105
23. I. Sivin, H. Croxatto, and L. Bahamondes Two-year performance of a Nestorone-releasing contraceptive implant: a three-center study of 300 women Contraception 69 2 2004 137 144
24. About Plan B Available at: http://go2planb.com Accessed November 11, 2004
25. H. Von Hertzen, G. Piaggio, and J. Ding Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multi-centre randomised trial Lancet 360 2002 1803 1810
26. C. Wang, and R. Swerdloff Male hormonal contraception Am J Obstet Gynecol 190 2004 S60 S68
27. J. Schwartz, and H. Gabelnick Current contraceptive research Perspect Sex Reprod Health 34 6 2002 310 316
28. Y. Gu, X. Wang, and D. Xu A multi-center contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men J Clin Endocrinol Metab 88 2003 562 568